$AILEQ
iLearningEngines, Inc.

2021 Q1 Form 10-Q Financial Statement

#000114036121018545 Filed on May 24, 2021

View on sec.gov

Income Statement

Concept 2021 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $942.5K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $942.5K
YoY Change
Operating Profit -$942.5K
YoY Change
Interest Expense $1.890K
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.573M
YoY Change
Pretax Income $1.631M
YoY Change
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $1.631M
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $45.37K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $871.5K
YoY Change
Cash & Equivalents $871.5K
Short-Term Investments
Other Short-Term Assets $1.021M
YoY Change
Inventory
Prepaid Expenses $1.021M
Receivables
Other Receivables
Total Short-Term Assets $1.892M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $287.5M
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $287.5M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.892M
Total Long-Term Assets $287.5M
Total Assets $289.4M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $126.9K
YoY Change
Accrued Expenses $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $126.9K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $28.16M
YoY Change
Total Long-Term Liabilities $28.16M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $126.9K
Total Long-Term Liabilities $28.16M
Total Liabilities $28.29M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$28.79M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$26.40M
YoY Change
Total Liabilities & Shareholders Equity $289.4M
YoY Change

Cashflow Statement

Concept 2021 Q1
OPERATING ACTIVITIES
Net Income $1.631M
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.078M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$287.5M
YoY Change
Cash From Investing Activities -$287.5M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 289.4M
YoY Change
NET CHANGE
Cash From Operating Activities -1.078M
Cash From Investing Activities -287.5M
Cash From Financing Activities 289.4M
Net Change In Cash 849.6K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$1.078M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1041
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
126935
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29281
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3370075
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5760691
CY2020Q4 us-gaap Assets
Assets
116532
CY2021Q1 us-gaap Assets
Assets
289394389
CY2021Q1 us-gaap Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current
AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent
0
CY2020Q4 us-gaap Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current
AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent
87215
CY2020Q4 us-gaap Assets Current
AssetsCurrent
21965
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1892498
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
0
CY2021Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
287501891
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
849561
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21965
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
871526
CY2021Q1 us-gaap Cash
Cash
871526
CY2020Q4 us-gaap Cash
Cash
21965
CY2021Q1 us-gaap Deferred Costs
DeferredCosts
0
CY2021Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-weight: bold;">Concentration of Credit Risk</div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</div></div>
CY2020Q4 us-gaap Deferred Costs
DeferredCosts
94567
CY2021Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
16392714
CY2021Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
16392714
CY2021Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
38290
CY2021Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2571250
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
18100000
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
20671250
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2571250
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1630620
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1020972
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
125894
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1891
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
289394389
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116532
CY2020Q4 us-gaap Liabilities
Liabilities
88256
CY2021Q1 us-gaap Liabilities
Liabilities
28289435
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
126935
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1077577
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1630620
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-287500000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
289427138
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
88256
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
942521
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-942521
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2573141
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
572862
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
287500000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1020972
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
281750000
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
287500000
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8250000
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8250000
CY2021Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
149992
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
149992
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1724
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1628896
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-761746
CY2021Q1 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
-760022
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
28276
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000004
CY2021Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2020Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
25610495
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
25610495
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
256104950
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-weight: bold;">Use of Estimates</div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">The preparation of the condensed financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div></div>
CY2021Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Arrowroot Acquisition Corp.
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001835972
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Shell Company
EntityShellCompany
true
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q4 arrw Deferred Underwriting Commissions
DeferredUnderwritingCommissions
0
CY2021Q1 arrw Deferred Underwriting Commissions
DeferredUnderwritingCommissions
10062500
CY2021Q1 arrw Deferred Underwriting Commissions
DeferredUnderwritingCommissions
10062500
CY2021Q1 arrw Shares Issued In Initial Public Offering During Period Value New Issues
SharesIssuedInInitialPublicOfferingDuringPeriodValueNewIssues
258786058
CY2021Q1 arrw Reclassifications Of Permanent To Temporary Equity Value
ReclassificationsOfPermanentToTemporaryEquityValue
256104950
CY2021Q1 arrw Excess Of Fair Value Paid By Private Placement Warrants Holders Value
ExcessOfFairValuePaidByPrivatePlacementWarrantsHoldersValue
660000
CY2021Q1 arrw Threshold Trading Days
ThresholdTradingDays
P20D
CY2021Q1 arrw Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.01
CY2021Q1 arrw Period To Exercise Warrants After Business Combination
PeriodToExerciseWarrantsAfterBusinessCombination
P30D
CY2021Q1 arrw Threshold Consecutive Trading Days
ThresholdConsecutiveTradingDays
P30D
CY2021Q1 arrw Period To Exercise Warrants After Closing Of Initial Public Offering
PeriodToExerciseWarrantsAfterClosingOfInitialPublicOffering
P12M
CY2021Q1 arrw Notice Period To Redeem Warrants
NoticePeriodToRedeemWarrants
P30D
CY2021Q1 arrw Period To File Registration Statement After Initial Business Combination
PeriodToFileRegistrationStatementAfterInitialBusinessCombination
P15D
CY2021Q1 arrw Period For Registration Statement To Become Effective
PeriodForRegistrationStatementToBecomeEffective
P60D
CY2021Q1 arrw Deferred Underwriting Fee Charged
DeferredUnderwritingFeeCharged
10062500
CY2021Q1 arrw Change In Value Of Ordinary Shares Subject To Possible Redemption
ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption
2390640
CY2021Q1 arrw Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
253714310
CY2021Q1 arrw Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
22625000
CY2021Q1 arrw Other Offering Costs
OtherOfferingCosts
580214
CY2021Q1 arrw Percentage Of Public Shares That Would Not Be Redeemed If Business Combination Is Not Completed Within Initial Combination Period
PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
1
CY2021Q1 arrw Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
10.00
CY2021Q1 arrw Net Tangible Asset Threshold For Redeeming Public Shares
NetTangibleAssetThresholdForRedeemingPublicShares
5000001
CY2021Q1 arrw Period To Complete Business Combination From Closing Of Initial Public Offering
PeriodToCompleteBusinessCombinationFromClosingOfInitialPublicOffering
P24M
CY2021Q1 arrw Underwriting Fees
UnderwritingFees
5750000
CY2021Q1 arrw Period To Redeem Public Shares If Business Combination Is Not Completed Within Initial Combination Period
PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
P10D
CY2021Q1 arrw Percentage Of Public Shares That Can Be Redeemed Without Prior Consent
PercentageOfPublicSharesThatCanBeRedeemedWithoutPriorConsent
0.15
CY2021Q1 arrw Stock Conversion Ratio
StockConversionRatio
1
CY2021Q1 arrw Stock Conversion As Converted Percentage
StockConversionAsConvertedPercentage
0.2
CY2021Q1 arrw Deferred Underwriter Fee Per Unit
DeferredUnderwriterFeePerUnit
0.35
CY2021Q1 arrw Interest Income Withdraw
InterestIncomeWithdraw
0
CY2021Q1 arrw Minimum Percentage Of Outstanding Shares In Tender Offer Provision
MinimumPercentageOfOutstandingSharesInTenderOfferProvision
0.5

Files In Submission

Name View Source Status
0001140361-21-018545-index-headers.html Edgar Link pending
0001140361-21-018545-index.html Edgar Link pending
0001140361-21-018545.txt Edgar Link pending
0001140361-21-018545-xbrl.zip Edgar Link pending
arrw-20210331.xml Edgar Link completed
arrw-20210331.xsd Edgar Link pending
arrw-20210331_cal.xml Edgar Link unprocessable
arrw-20210331_def.xml Edgar Link unprocessable
arrw-20210331_lab.xml Edgar Link unprocessable
arrw-20210331_pre.xml Edgar Link unprocessable
brhc10024998_10q.htm Edgar Link pending
brhc10024998_ex31-1.htm Edgar Link pending
brhc10024998_ex31-2.htm Edgar Link pending
brhc10024998_ex32-1.htm Edgar Link pending
brhc10024998_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending